Sorbitol Dehydrogenase Sord Deficiency clinical trials

Explore recruiting sorbitol dehydrogenase sord deficiency clinical trials.

Also recruiting in Europe

Sorbitol Dehydrogenase Sord Deficiency trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A RandomIzed, Double-Blind, Placebo-CoNtrolled, Two-Part Study to Evaluate the Pharmacodynamic EffIcacy and Clinical Benefit of AT 007 in Patients with SoRbitol Dehydrogenase (SORD) DEficiency

Czechia, Italy

Phase II and Phase III (Integrated) EU CTIS Study details

Sorbitol Dehydrogenase Sord Deficiency trials by city

Sorbitol Dehydrogenase Sord Deficiency in Toronto Sorbitol Dehydrogenase Sord Deficiency in Vancouver Sorbitol Dehydrogenase Sord Deficiency in Montreal Sorbitol Dehydrogenase Sord Deficiency in Calgary Sorbitol Dehydrogenase Sord Deficiency in Edmonton Sorbitol Dehydrogenase Sord Deficiency in Ottawa Sorbitol Dehydrogenase Sord Deficiency in Winnipeg Sorbitol Dehydrogenase Sord Deficiency in Quebec City Sorbitol Dehydrogenase Sord Deficiency in Hamilton Sorbitol Dehydrogenase Sord Deficiency in Kitchener Sorbitol Dehydrogenase Sord Deficiency in London Sorbitol Dehydrogenase Sord Deficiency in Halifax Sorbitol Dehydrogenase Sord Deficiency in New York Sorbitol Dehydrogenase Sord Deficiency in Los Angeles Sorbitol Dehydrogenase Sord Deficiency in Chicago Sorbitol Dehydrogenase Sord Deficiency in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease